Green Light photoselective vaporization of the prostate: a safe and effective treatment for elderly high-risk benign prostate hyperplasia patients with gland over 80 ml
- 161 Downloads
To analyze the efficacy of Green Light photoselective vaporization of the prostate (PVP) in elderly high-risk benign prostatic hyperplasia (BPH) patients with glands over 80 ml. From December 2013 to February 2016, we allocated 84 elderly (age 71–97) high-risk patients who underwent preoperative transrectal ultrasound (TRUS) examination with glands over 80 ml and divided them into two groups to receive 120 W (n = 40) and 180 W (n = 44) PVP. All the patients have been observed at least one intraoperative comorbidity: hypertension, diabetes mellitus, NYHA II, or combined. They were followed up for 12 months. All the conventional parameters were compared in this study. All the patients received successful operations without severe complications, and no patient needed blood transfusion. The operation time and catheterization time of the 180 W patients were significantly shorter than that of the 120 W patients (p < 0.05). The International Prostate Symptom Scores (IPSS), quality of life (QoL) scores, maximum flow rate (Qmax), and residual urine volume (RUV) in both groups have been significantly improved. PVP is safe and effective for high-risk aging patients with gland over 80 ml. In addition, 180 W XPS system has a short operation time and catheterization time and less inflammatory response.
KeywordsBenign prostatic hyperplasia (BPH) Lower urinary tract symptoms Photoselective vaporization of the prostate (PVP) High-risk Aging population
Compliance with ethical standards
All patients have signed informed consent documents and agreed to receive the treatment. This study has been proved by the Ethics Committee of our hospital.
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W, Abrams P (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50(6):1306–1314; discussion 1314-1305. https://doi.org/10.1016/j.eururo.2006.09.019 CrossRefGoogle Scholar
- 6.Christidis D, McGrath S, Perera M, Manning T, Bolton D, Lawrentschuk N (2017) Minimally invasive surgical therapies for benign prostatic hypertrophy: the rise in minimally invasive surgical therapies. Prostate Int 5(2):41–46. https://doi.org/10.1016/j.prnil.2017.01.007 CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Bachmann A, Muir GH, Collins EJ, Choi BB, Tabatabaei S, Reich OM, Gomez-Sancha F, Woo HH (2012) 180-W XPS GreenLight laser therapy for benign prostate hyperplasia: early safety, efficacy, and perioperative outcome after 201 procedures. Eur Urol 61(3):600–607. https://doi.org/10.1016/j.eururo.2011.11.041 CrossRefPubMedGoogle Scholar
- 10.Al-Ansari A, Younes N, Sampige VP, Al-Rumaihi K, Ghafouri A, Gul T, Shokeir AA (2010) GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol 58(3):349–355. https://doi.org/10.1016/j.eururo.2010.05.026 CrossRefPubMedGoogle Scholar
- 12.Bachmann A, Tubaro A, Barber N, d'Ancona F, Muir G, Witzsch U, Grimm MO, Benejam J, Stolzenburg JU, Riddick A, Pahernik S, Roelink H, Ameye F, Saussine C, Bruyere F, Loidl W, Larner T, Gogoi NK, Hindley R, Muschter R, Thorpe A, Shrotri N, Graham S, Hamann M, Miller K, Schostak M, Capitan C, Knispel H, Thomas JA (2014) 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial—the GOLIATH study. Eur Urol 65(5):931–942. https://doi.org/10.1016/j.eururo.2013.10.040 CrossRefPubMedGoogle Scholar
- 14.Lee DJ, Rieken M, Halpern J, Zhao F, Pueschel H, Chughtai B, Kaplan SA, Lee RK, Bachmann A, Te AE (2016) Laser vaporization of the prostate with the 180-W XPS-Greenlight laser in patients with ongoing platelet aggregation inhibition and oral anticoagulation. Urology 91:167–173. https://doi.org/10.1016/j.urology.2016.01.021 CrossRefPubMedGoogle Scholar
- 17.Pathak RA, Broderick GA, Igel TC, Petrou SP, Young PR, Wehle MJ, Heckman MG, Diehl NN, Vargas ER, Shah K, Thiel DD (2017) Impact of minimally invasive benign prostatic hyperplasia therapies on 30- and 90-day postoperative office encounters. Urology 99:186–191. https://doi.org/10.1016/j.urology.2016.10.015 CrossRefPubMedGoogle Scholar
- 18.Berquet G, Corbel L, Della Negra E, Huet R, Trifard F, Codet Y, Bouliere F, Verhoest G, Vincendeau S, Bensalah K, Mathieu R (2015) Prospective evaluation of ambulatory laser vaporization of the prostate for benign prostatic hyperplasia. Lasers Surg Med 47(5):396–402. https://doi.org/10.1002/lsm.22363 CrossRefPubMedGoogle Scholar
- 19.Bouchier-Hayes DM, Van Appledorn S, Bugeja P, Crowe H, Challacombe B, Costello AJ (2010) A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU Int 105(7):964–969. https://doi.org/10.1111/j.1464-410X.2009.08961.x CrossRefPubMedGoogle Scholar
- 20.Lukacs B, Loeffler J, Bruyere F, Blanchet P, Gelet A, Coloby P, De la Taille A, Lemaire P, Baron JC, Cornu JN, Aout M, Rousseau H, Vicaut E, Group RS (2012) Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial. Eur Urol 61(6):1165–1173. https://doi.org/10.1016/j.eururo.2012.01.052 CrossRefPubMedGoogle Scholar
- 22.Eken A, Soyupak B, Acil M, Arpaci T, Akbas T (2015) Safety, efficacy and outcomes of the new GreenLight XPS 180W laser system compared to the GreenLight HPS 120W system for the treatment of benign prostatic hyperplasia in a prospective nonrandomized single-centre study. Can Urol Assoc J 9(1–2):e56–e60. https://doi.org/10.5489/cuaj.2263 CrossRefPubMedPubMedCentralGoogle Scholar
- 23.Sohn JH, Choi YS, Kim SJ, Cho HJ, Hong SH, Lee JY, Hwang TK, Kim SW (2011) Effectiveness and safety of photoselective vaporization of the prostate with the 120 W HPS Greenlight laser in benign prostatic hyperplasia patients taking oral anticoagulants. Korean J Urol 52(3):178–183. https://doi.org/10.4111/kju.2011.52.3.178 CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Ben-Zvi T, Hueber PA, Liberman D, Valdivieso R, Zorn KC (2013) GreenLight XPS 180W vs HPS 120W laser therapy for benign prostate hyperplasia: a prospective comparative analysis after 200 cases in a single-center study. Urology 81(4):853–858. https://doi.org/10.1016/j.urology.2012.12.031 CrossRefPubMedGoogle Scholar
- 27.Luo F, Sun HH, Su YH, Zhang ZH, Wang YS, Zhao Z, Li J (2017) GreenLight laser photoselective vaporization of the prostate for treatment of benign prostate hyperplasia/lower urinary tract symptoms in patients with different post-void residual urine. Lasers Med Sci 32(4):895–901. https://doi.org/10.1007/s10103-017-2190-1 CrossRefPubMedGoogle Scholar
- 28.Hueber PA, Liberman D, Ben-Zvi T, Woo H, Hai MA, Te AE, Chughtai B, Lee R, Rutman M, Gonzalez RR, Barber N, Al-Hathal N, Al-Qaoud T, Trinh QD, Zorn KC (2013) 180 W vs 120 W lithium triborate photoselective vaporization of the prostate for benign prostatic hyperplasia: a global, multicenter comparative analysis of perioperative treatment parameters. Urology 82(5):1108–1113. https://doi.org/10.1016/j.urology.2013.03.059 CrossRefPubMedGoogle Scholar
- 30.Cho MC, Ha SB, Oh SJ, Kim SW, Paick JS (2015) Change in storage symptoms following laser prostatectomy: comparison between photoselective vaporization of the prostate (PVP) and holmium laser enucleation of the prostate (HoLEP). World J Urol 33(8):1173–1180. https://doi.org/10.1007/s00345-014-1424-0 CrossRefPubMedGoogle Scholar